Study guide
2.2 Transcutaneous Electrical Nerve Stimulation (TENS) Modes & Protocols
NBCE Physiotherapy Examination Exam
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Clinical Foundations, Healing Physiology & Scope of Practice
1.1 NBCE Physiotherapy Examination & Scope of Practice 1.2 Tissue Healing Phases & Biological Repair Mechanisms 1.3 Pain Neurophysiology & Pain Modulation Theories
2 Chapter 2: Electrotherapy Foundations & Pain Modulation Modalities
2.1 Principles of Electricity, Waveforms & Current Density 2.2 Transcutaneous Electrical Nerve Stimulation (TENS) Modes & Protocols 2.3 Interferential Current (IFC) & Premodulated Current Therapy
3 Chapter 3: Neuromuscular Stimulation & Advanced Electrotherapy Modalities
3.1 Neuromuscular Electrical Stimulation (NMES) & Russian Stimulation 3.2 High-Voltage Pulsed Current (HVPC) & Microcurrent Electrical Therapy 3.3 Iontophoresis Biophysics, Pharmacology & Dosing Protocols
4 Chapter 4: Thermal Modalities — Cryotherapy & Superficial Heat
4.1 Cryotherapy Biophysics, Hunting Reaction & Clinical Protocols 4.2 Superficial Heat: Hydrocollator Moist Packs & Paraffin Bath 4.3 Fluidotherapy & Radiant Infrared Heat Modalities
5 Chapter 5: Therapeutic Ultrasound, Phonophoresis & Deep Heat
5.1 Ultrasound Biophysics, Frequency Selection & Beam Metrics (BNR & ERA) 5.2 Thermal vs. Non-Thermal Ultrasound & Treatment Parameters 5.3 Phonophoresis Protocols & Ultrasound-Electrotherapy Combination
6 Chapter 6: Mechanotherapy — Traction, Soft Tissue, Bracing & Taping
6.1 Cervical Mechanical Traction: Angles, Force Parameters & Protocols 6.2 Lumbar Mechanical Traction: Positioning, Force & Table Dynamics 6.3 Intermittent Pneumatic Compression, CPM & Mechanotherapy 6.4 Therapeutic Massage, Vibration & Trigger Point Therapy 6.5 Bracing & Orthotic Prescription 6.6 Therapeutic Taping: Rigid, McConnell & Elastic Techniques
7 Chapter 7: Hydrotherapy & Phototherapy (Light Therapy)
7.1 Hydrotherapy Principles, Whirlpool Therapy & Contrast Baths 7.2 Low-Level Laser Therapy (Photobiomodulation) & Biophysics 7.3 Ultraviolet Therapy (UVA/UVB) & Radiant Infrared Therapy
8 Chapter 8: Functional Assessment, Exercise Physiology & Muscle Rehabilitation
8.1 Exercise Physiology Foundations: Bioenergetics, Fiber Types & Muscle Contractions 8.2 Range of Motion, Therapeutic Stretching & PNF Techniques 8.3 Postural Syndromes, Janda's Classifications & Functional Movement Assessment 8.4 Gait Cycle Analysis & Pathological Gait Patterns 8.5 Neurobiology of Training: Motor Unit Recruitment, Neural Adaptation & Motor Learning 8.6 Strengthening: Progressive Resistance Exercise & Loading Prescription
9 Chapter 9: Neuromuscular Rehabilitation — Balance, Motor Control & Spine Stabilization
9.1 Spinal Stabilization Mechanics & Stuart McGill's Core Protocols 9.2 Cervical Spine Rehabilitation: Radiculopathy, Whiplash & Postural Syndromes 9.3 Lumbar Spine Rehabilitation: Disc Herniation, Stenosis & Spondylolisthesis 9.4 Balance, Postural Alignment & Sensorimotor Training 9.5 Coordinated Movement Patterns & Motor Control Retraining 9.6 Sacroiliac Joint & Pelvic Girdle Rehabilitation
10 Chapter 10: Extremity Rehabilitation, Clinical Safety & CPT Documentation
10.1 Upper Extremity Rehabilitation: Rotator Cuff, Impingement, Epicondylalgia & Carpal Tunnel 10.2 Lower Extremity Rehabilitation: Patellofemoral Pain, ACL, Achilles Tendinopathy & Plantar Fasciitis 10.3 Universal Modality Contraindications, Safety Screening & Red Flags 10.4 Physical Medicine CPT Coding (97000 Series), 8-Minute Rule & SOAP Documentation
11 Chapter 11: Endurance Training & Cardiovascular Rehabilitation
11.1 Aerobic Capacity, VO2max & Cardiorespiratory Adaptation 11.2 Aerobic Exercise Prescription: FITT-VP, Intensity Monitoring & Progression 11.3 Cardiovascular Rehabilitation: Risk Stratification, Phases & Safety Limits
2.2 Transcutaneous Electrical Nerve Stimulation (TENS) Modes & Protocols
Key Takeaways Explain This Topic AI
Conventional (high-rate/sensory) TENS utilizes high frequency (50–150 Hz), narrow pulse width (50–100 μs), and sensory-level amplitude to close the spinal pain gate via large-diameter A-beta fiber activation without muscle contraction.
Low-frequency (acupuncture-like/motor) TENS utilizes low frequency (1–10 Hz, typically 2–4 Hz), wide pulse width (150–300 μs), and rhythmic muscle twitches to stimulate endogenous opiate release (beta-endorphin), yielding 4–6 hours of post-treatment carryover analgesia.
Brief Intense TENS operates at high frequency (100–150 Hz) and wide pulse width (150–250 μs) at noxious tolerable amplitudes for 10–15 minutes, activating descending noxious inhibitory control (DNIC) prior to painful rehabilitation interventions.
Waveform modulation (cycling frequency, pulse duration, or amplitude) prevents nervous system accommodation, ensuring sustained therapeutic efficacy over prolonged treatment durations.
Absolute contraindications include demand cardiac pacemakers/AICDs, carotid sinus placement, active thrombophlebitis, phrenic nerve/anterior neck, the gravid uterus during pregnancy, transcerebral electrode arrays, and uncontrolled epilepsy.
Last updated: September 2026
Transcutaneous Electrical Nerve Stimulation (TENS) Modes & Protocols
Transcutaneous Electrical Nerve Stimulation (TENS) is an evidence-based electrotherapeutic modality designed specifically for the non-invasive, non-pharmacological management of acute, subacute, and chronic pain. In chiropractic clinical practice, TENS serves as a critical adjunctive tool to downregulate central and peripheral nociception, break the reflexive pain-spasm-pain cycle, and create a therapeutic window for active rehabilitation and spinal manipulative therapy.
The Neurobiological Mechanisms of TENS
TENS modulates pain perception primarily through two distinct neurophysiological mechanisms:
The Spinal Gate Control Theory (Melzack & Wall, 1965): Non-noxious sensory input conveyed along large-diameter, myelinated A β \text{A}\beta A β (A-beta) afferent fibers enters the dorsal horn of the spinal cord. These fibers send collateral branches into the substantia gelatinosa (Laminae II and III) , exciting inhibitory GABAergic and enkephalinergic interneurons. These interneurons presynaptically inhibit the central transmission cells ( T-cells ) in Lamina V, closing the "gate" against incoming noxious impulses carried by small-diameter A δ \text{A}\delta A δ (A-delta) and C fibers traveling up the spinothalamic tract.
The Endogenous Opioid Hypothesis: Low-frequency, rhythmic motor-level stimulation activates muscle ergoreceptors (Group III and IV afferents), transmitting signals via the spinothalamic tract to the periaqueductal gray (PAG) matter of the midbrain and the nucleus raphe magnus (NRM) of the rostral ventromedial medulla. This triggers the synthesis and systemic release of β \beta β -endorphin from the pituitary gland and hypothalamus, along with dynorphins and enkephalins in the cerebrospinal fluid. These endogenous peptides bind to μ \mu μ - and δ \delta δ -opioid receptors, depressing pain transmission at both presynaptic and postsynaptic sites. This analgesic mechanism can be experimentally blocked by the opioid antagonist naloxone .
Clinical Comparison of the Four TENS Modes
Clinical success with TENS requires prescribing specific parameter sets tailored to the patient's pathology, chronicity, and tolerance.
1. Conventional TENS (High-Frequency / Sensory-Level)
Frequency: High, 50 – 150 Hz 50–150\text{ Hz} 50–150 Hz (typically set at 80 – 100 pps 80–100\text{ pps} 80–100 pps ).
Pulse Duration: Narrow, 50 – 100 μ s 50–100\ \mu s 50–100 μ s .
Amplitude / Intensity: Sensory-level. The patient experiences a comfortable, strong, non-painful tingling, fluttering, or buzzing sensation beneath and between the pads. No muscle twitches or contractions should be visible or palpable.
Mechanism: Exclusively Gate Control Theory (selective A β \text{A}\beta A β depolarization).
Onset of Analgesia: Rapid (typically within 5 – 15 minutes 5–15\text{ minutes} 5–15 minutes ). However, the analgesic carryover post-treatment is short (typically 30 minutes to 2 hours 30\text{ minutes to }2\text{ hours} 30 minutes to 2 hours after shutting off the unit).
Treatment Duration: 30 – 60 minutes 30–60\text{ minutes} 30–60 minutes , or worn continuously during daily functional activities.
Indications: Acute musculoskeletal injuries (e.g., acute cervical whiplash, acute lumbar sprain/strain), post-surgical incision pain, acute radiculopathy flare-ups, and early-phase joint inflammation.
2. Low-Frequency TENS (Acupuncture-Like / Motor-Level)
Frequency: Low, 1 – 10 Hz 1–10\text{ Hz} 1–10 Hz (optimally 2 – 4 pps 2–4\text{ pps} 2–4 pps ).
Pulse Duration: Wide, 150 – 300 μ s 150–300\ \mu s 150–300 μ s .
Amplitude / Intensity: Motor-level. Adjusted until visible, rhythmic, forceful muscle fasciculations or twitches occur at the set frequency (e.g., 2–4 rhythmic contractions per second). The contractions must remain tolerable without inducing cramp or sharp pain.
Mechanism: Endogenous Opioid Release (systemic β \beta β -endorphin and dynorphin release; completely reversed by naloxone administration).
Onset of Analgesia: Delayed (requires 20 – 30 minutes 20–30\text{ minutes} 20–30 minutes of stimulation to achieve therapeutic circulating opioid concentrations).
Carryover Effect: Substantial and prolonged ( 4 – 6 + hours 4–6+\text{ hours} 4–6 + hours of post-treatment pain reduction).
Treatment Duration: Strictly limited to 20 – 30 minutes 20–30\text{ minutes} 20–30 minutes . Prolonged continuous motor stimulation causes local muscular fatigue, micro-trauma, and delayed-onset muscle soreness (DOMS).
Indications: Chronic pain syndromes (chronic myofascial pain syndrome, chronic lumbosacral spondylosis, osteoarthritis, post-stroke shoulder subluxation pain).
3. Brief Intense TENS (Noxious-Level)
Frequency: High, 100 – 150 Hz 100–150\text{ Hz} 100–150 Hz .
Pulse Duration: Wide, 150 – 250 μ s 150–250\ \mu s 150–250 μ s .
Amplitude / Intensity: Noxious / maximal tolerable. Current is driven to the patient's highest tolerable tolerance, eliciting intense non-painful or painful paresthesia combined with tetanic muscle contraction.
Mechanism: Descending Noxious Inhibitory Control (DNIC) and temporary peripheral axon conduction block. The overwhelming sensory barrage temporarily depletes presynaptic neurotransmitter pools and triggers descending serotonergic and noradrenergic inhibitory tracts from the brainstem.
Onset of Analgesia: Immediate, producing profound local anesthesia/numbness.
Carryover Effect: Short to moderate ( 30 – 60 minutes 30–60\text{ minutes} 30–60 minutes ).
Treatment Duration: Brief, 10 – 15 minutes 10–15\text{ minutes} 10–15 minutes maximum .
Indications: Applied immediately prior to painful therapeutic interventions, such as deep friction cross-fiber massage, aggressive manual joint mobilization, passive contracture stretching, or trigger point dry needling.
4. Burst Mode TENS (Pulse-Train / Combination)
Waveform Structure: High-frequency carrier pulses (typically 70 – 100 Hz 70–100\text{ Hz} 70–100 Hz ) grouped into discreet "packets" or bursts delivered at a low repetition rate of 1 – 5 bursts per second 1–5\text{ bursts per second} 1–5 bursts per second .
Pulse Duration: Moderate, 100 – 200 μ s 100–200\ \mu s 100–200 μ s .
Amplitude / Intensity: Set to produce visible rhythmic muscle contractions at the burst frequency (e.g., 2 to 3 rhythmic muscle beats per second).
Mechanism: Combines both the Gate Control Theory and Endogenous Opiate Release pathways.
Clinical Rationale: Single pulses delivered at low frequencies (2 Hz) in Acupuncture-like TENS can feel sharp, pricking, or stinging to sensitive patients. Grouping pulses into bursts delivers high electrical charge more comfortably, enhancing patient compliance while still eliciting forceful motor contractions and endorphin synthesis.
Comparison of TENS Modes
TENS Mode Target Sensory/Motor Frequency ( H z Hz Hz ) Pulse Width ( μ s \mu s μ s ) Primary Mechanism Onset Speed Carryover Analgesia Treatment Time
Conventional Sensory (Tingling) 50 – 150 Hz 50–150\text{ Hz} 50–150 Hz 50 – 100 μ s 50–100\ \mu s 50–100 μ s Gate Control ( A β \text{A}\beta A β ) Rapid ( < 15 min <15\text{ min} < 15 min ) Short ( 0.5 – 2 hr 0.5–2\text{ hr} 0.5–2 hr ) 30 – 60 min 30–60\text{ min} 30–60 min (or continuous)
Low-Frequency (Acupuncture-like) Motor (Visible Twitch) 1 – 10 Hz 1–10\text{ Hz} 1–10 Hz ( 2 – 4 2–4 2–4 ) 150 – 300 μ s 150–300\ \mu s 150–300 μ s β \beta β -Endorphin / Opiates Delayed ( 20 – 30 min 20–30\text{ min} 20–30 min ) Long ( 4 – 6 hr 4–6\text{ hr} 4–6 hr ) 20 – 30 min 20–30\text{ min} 20–30 min maximum
Brief Intense Noxious (Paresthesia + Tetany) 100 – 150 Hz 100–150\text{ Hz} 100–150 Hz 150 – 250 μ s 150–250\ \mu s 150–250 μ s DNIC / Conduction Block Immediate Short ( 0.5 – 1 hr 0.5–1\text{ hr} 0.5–1 hr ) 10 – 15 min 10–15\text{ min} 10–15 min maximum
Burst Mode Mixed (Sensory + Motor Bursts) 70 – 100 Hz 70–100\text{ Hz} 70–100 Hz in 1 – 5 bps 1–5\text{ bps} 1–5 bps 100 – 200 μ s 100–200\ \mu s 100–200 μ s Dual: Gate + Opiates Moderate ( 15 – 20 min 15–20\text{ min} 15–20 min ) Moderate-Long ( 3 – 5 hr 3–5\text{ hr} 3–5 hr ) 20 – 30 min 20–30\text{ min} 20–30 min
Prevention of Nerve Accommodation: Modulation Parameters
A persistent clinical challenge during prolonged TENS application is accommodation —the physiological process whereby nerve cell membranes adapt to constant, repetitive electrical stimuli by raising their depolarization threshold. Patients report that the stimulation "faded away" after 10–15 minutes, leading to reduced analgesia.
Modern digital TENS units combat accommodation by incorporating automated Modulation Modes that dynamically cycle parameter settings in regular or random sequences:
Frequency Modulation (FM): The unit automatically sweeps the pulse rate across a preset range (e.g., cycling from 50 Hz 50\text{ Hz} 50 Hz to 100 Hz 100\text{ Hz} 100 Hz and back over a 5-second cycle). This prevents accommodation of the spinal interneurons.
Pulse Width Modulation (PWM): The unit continually widens and narrows the pulse duration by ± 25 – 50 % \pm 25–50\% ± 25–50% .
Amplitude Modulation (AM): The peak current automatically ramps up and down in intensity.
Multi-Modulation (Comb): Simultaneously varies frequency, width, and amplitude. Recommended whenever TENS is applied for extended sessions ( > 45 minutes >45\text{ minutes} > 45 minutes ).
Clinical Electrode Placement Strategies
Electrode positioning directly governs which neural pathways are recruited. Clinicians utilize four primary placement configurations:
Dermatomal / Spinal Segmental Placement: Electrodes are positioned along the paraspinal nerve root emergence corresponding to the spinal segment supplying the painful extremity (e.g., L4–S1 paraspinals for posterolateral sciatica, or C5–C7 paraspinals for cervical radiculopathy). This addresses referred and radicular pain at the spinal level.
Peripheral Nerve Pathway: Electrodes are placed directly along the anatomical course of the peripheral nerve proximal to the lesion site (e.g., along the superficial trunk of the common peroneal or ulnar nerve).
Bracketed / Criss-Cross Placement (Dual Channel): Four electrodes (two channels) surround the focal area of pain. Channel 1 and Channel 2 are aligned diagonally such that the lines between pad pairs cross over the central point of pain (e.g., enclosing an arthritic knee, glenohumeral joint, or lumbar facet arthropathy).
Myofascial Trigger Points and Acupuncture Points: Electrodes are positioned directly over localized hyperirritable nodules in taut muscle bands. These sites exhibit reduced electrical skin resistance, optimizing current penetration into somatic sensory pathways.
Absolute Contraindications and Clinical Safety Guidelines
Prior to applying TENS, the chiropractic clinician must perform pre-treatment sensory testing (light touch / sharp-dull) and rule out absolute contraindications:
Cardiac Pacemakers & AICDs: Electrical signals can interfere with demand-type cardiac pacemakers or implantable cardioverter-defibrillators, inducing pacing inhibition or triggering inappropriate defibrillation shocks. (Absolute contraindication anywhere on the torso or upper extremities).
Carotid Sinus Region: Placing electrodes over the anterior/lateral neck (carotid bifurcation) can stimulate baroreceptors, triggering sudden profound bradycardia, acute hypotension, and syncope.
Active Thrombophlebitis / DVT: Stimulation over veins with suspected or confirmed thrombosis can mechanically dislodge a clot, leading to pulmonary embolism.
Anterior Neck / Phrenic Nerve / Laryngeal Muscles: Risk of inducing vocal cord adduction, laryngeal spasm, and respiratory arrest.
Gravid Uterus During Pregnancy: Placement over the abdomen, pelvis, lower back, or sacrum during pregnancy is strictly contraindicated due to the risk of inducing premature uterine contractions. (TENS may be used on the lower extremities for distal neuropathies, or during active labor by trained obstetrical personnel).
Transcerebral / Transthoracic Lead Placement: Never place electrodes across the cranium (seizure risk) or transthoracically (across the heart vector, ventricular fibrillation risk).
Active Local Malignancy: Electrotherapy enhances microvascular perfusion and cellular metabolic activity, potentially promoting neoplastic metastasis.
Uncontrolled Epilepsy: Transcerebral or upper spinal leads can provoke seizure activity.
Impaired Sensation / Denervated Skin: Severe diabetic neuropathy or sensory loss impairs patient feedback, increasing burn risk.